CXCL5 limits macrophage foam cell formation in atherosclerosis

Area of Science:

• Immunology
• Cardiovascular Research
• Molecular Biology

Background:

• ELR(+) CXCL chemokines are known neutrophil chemoattractants in acute inflammation.
• The function of these chemokines in chronic inflammatory diseases like atherosclerosis is largely unknown.

Purpose of the Study:

• To investigate the role of CXCL5 in atherosclerosis.
• To understand the mechanisms underlying CXCL5's function in this disease context.

Main Methods:

• Utilized a mouse model of atherosclerosis.
• Analyzed CXCL5 expression during disease progression.
• Investigated the effects of CXCL5 inhibition on plaque development.
• Examined CXCL5's impact on macrophage activation and cholesterol metabolism.

Main Results:

• CXCL5 expression increased with atherosclerosis progression, independent of neutrophil infiltration.
• Inhibiting CXCL5 exacerbated plaque formation by promoting macrophage foam cell accumulation.
• CXCL5 was found to modulate macrophage activation and enhance cholesterol efflux via ABCA1.

Conclusions:

• CXCL5 plays a protective role in atherosclerosis by regulating macrophage foam cell formation.
• The findings challenge the traditional view of CXCL chemokines and highlight a novel therapeutic target for atherosclerosis.